All Relations between microtubule-associated protein tau and cannabis

Publication Sentence Publish Date Extraction Date Species
Itxaso González-Ortega, Enrique Echeburúa, Susana Alberich, Miguel Bernardo, Eduard Vieta, Gonzalo Salazar de Pablo, Ana González-Pint. Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial. International journal of environmental research and public health. vol 19. issue 12. 2022-06-24. PMID:35742573. the cbt-cc group had a greater decrease in cannabis use severity and positive psychotic symptoms over time, and a greater improvement in functioning at post-treatment than tau. 2022-06-24 2023-08-14 human
Itxaso González-Ortega, Enrique Echeburúa, Susana Alberich, Miguel Bernardo, Eduard Vieta, Gonzalo Salazar de Pablo, Ana González-Pint. Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial. International journal of environmental research and public health. vol 19. issue 12. 2022-06-24. PMID:35742573. the treatment response was also faster in the cbt-cc group, reducing cannabis use, anxiety, positive and general psychotic symptoms, and improving functioning earlier than tau in the follow-up. 2022-06-24 2023-08-14 human
Itxaso González-Ortega, Enrique Echeburúa, Susana Alberich, Miguel Bernardo, Eduard Vieta, Gonzalo Salazar de Pablo, Ana González-Pint. Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial. International journal of environmental research and public health. vol 19. issue 12. 2022-06-24. PMID:35742573. the aim of this study was to compare the efficacy of a specific cognitive behavioral therapy (cbt) for cannabis cessation (cbt-cc) with treatment as usual (tau) in fep cannabis users. 2022-06-24 2023-08-14 human
David B Goldston, John F Curry, Karen C Wells, Yifrah Kaminer, Stephanie S Daniel, Christianne Esposito-Smythers, Otima Doyle, Jeffrey Sapyta, Angela M Tunno, Nicole C Heilbron, Michelle Roley-Robert. Feasibility of an Integrated Treatment Approach for Youth with Depression, Suicide Attempts, and Substance Use Problems. Evidence-based practice in child and adolescent mental health. vol 6. issue 2. 2022-06-13. PMID:35692895. reductions in alcohol and marijuana problems were similar, but half of the youth in tau alone (and none in the cbt-rp + tau group) had emergency department visits related to psychiatric crises or substance related problems. 2022-06-13 2023-08-14 Not clear
Inés Campo Ferreiro, Maria Assumpta Rigol Cuadra, Francesca Asensio Serqueda, Josep Maria Haro Aba. Impact of Housing First on Psychiatric Symptoms, Substance Use, and Everyday Life Skills Among People Experiencing Homelessness. Journal of psychosocial nursing and mental health services. 2022-03-22. PMID:35316121. at 21 months, the hf group presented significantly better outcomes regarding alcohol and cannabis use than the tau group. 2022-03-22 2023-08-13 human
Inés Campo Ferreiro, Maria Assumpta Rigol Cuadra, Francesca Asensio Serqueda, Josep Maria Haro Aba. Impact of Housing First on Psychiatric Symptoms, Substance Use, and Everyday Life Skills Among People Experiencing Homelessness. Journal of psychosocial nursing and mental health services. 2022-03-22. PMID:35316121. moreover, the subgroup of hf participants with severe mental illness had significant improvements in psychotic symptoms, anxiety, depression, social relations, and cannabis use compared to tau participants. 2022-03-22 2023-08-13 human
Soha Alali, Gholamhossein Riazi, Mohammad Reza Ashrafi-Kooshk, Sogol Meknatkhah, Shahin Ahmadian, Mohammad Hooshyari Ardakani, Baharak Hosseinkhan. Cannabidiol Inhibits Tau Aggregation In Vitro. Cells. vol 10. issue 12. 2021-12-24. PMID:34944028. cannabidiol inhibits tau aggregation in vitro. 2021-12-24 2023-08-13 Not clear
A Schneegans, F Bourgognon, E Albuisson, R Schwan, M Arfa, L Polli, M Moulard, V Laprévote, T Schwitze. Mindfulness-based relapse prevention for cannabis regular users: Preliminary outcomes of a randomized clinical trial. L'Encephale. 2021-06-07. PMID:34092381. twenty cannabis users were randomly assigned to either receive an eight-week outpatient mbrp program or treatment as usual (tau). 2021-06-07 2023-08-13 human
Zoë E Papinczak, Jason P Connor, Gerald F X Feeney, Matthew J Gull. Additive effectiveness and feasibility of a theory-driven instant assessment and feedback system in brief cannabis intervention: A randomised controlled trial. Addictive behaviors. vol 113. 2021-05-14. PMID:33075644. this study evaluated the feasibility and additive effectiveness of the iax on motivation to change cannabis use, when compared to treatment as usual (tau), in a single-session bi. 2021-05-14 2023-08-13 Not clear
Tim Karl, Brett Garner, David Chen. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease. Behavioural pharmacology. vol 28. issue 2 and 3-Spec Issue. 2018-01-11. PMID:27471947. the phytocannabinoid cannabidiol (cbd) possesses neuroprotective, antioxidant and anti-inflammatory properties and reduces amyloid-β production and tau hyperphosphorylation in vitro. 2018-01-11 2023-08-13 Not clear
C R Hjorthøj, A Fohlmann, A-M Larsen, C Gluud, M Arendt, M Nordentof. Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological medicine. vol 43. issue 7. 2014-02-17. PMID:23040144. method a total of 103 patients with psychosis and cannabis use disorder were centrally randomized to 6 months of capopus plus tau (n = 52) or tau (n = 51). 2014-02-17 2023-08-12 Not clear
C R Hjorthøj, A Fohlmann, A-M Larsen, C Gluud, M Arendt, M Nordentof. Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological medicine. vol 43. issue 7. 2014-02-17. PMID:23040144. specialized psychosocial treatment plus treatment as usual (tau) versus tau for patients with cannabis use disorder and psychosis: the capopus randomized trial. 2014-02-17 2023-08-12 Not clear
C R Hjorthøj, A Fohlmann, A-M Larsen, C Gluud, M Arendt, M Nordentof. Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological medicine. vol 43. issue 7. 2014-02-17. PMID:23040144. we investigated whether adding capopus to treatment as usual (tau) reduces cannabis use in patients with cannabis use disorder and psychosis. 2014-02-17 2023-08-12 Not clear
Maria J Casarejos, Juan Perucho, Ana Gomez, Maria P Muñoz, Marian Fernandez-Estevez, Onintza Sagredo, Javier Fernandez Ruiz, Manuel Guzman, Justo Garcia de Yebenes, Maria A Men. Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. Journal of Alzheimer's disease : JAD. vol 35. issue 3. 2013-10-17. PMID:23478312. we tested the effects of sativex®, a mixture of Δ9-tetrahydrocannabinol and cannabidiol, acting on both cb1 and cb2 receptors, in parkin-null, human tau overexpressing (pk-/-/tauvlw) mice, a model of complex frontotemporal dementia, parkinsonism, and lower motor neuron disease. 2013-10-17 2023-08-12 mouse
Giuseppe Esposito, Daniele De Filippis, Rosa Carnuccio, Angelo A Izzo, Teresa Iuvon. The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. Journal of molecular medicine (Berlin, Germany). vol 84. issue 3. 2006-08-30. PMID:16389547. the marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through wnt/beta-catenin pathway rescue in pc12 cells. 2006-08-30 2023-08-12 Not clear
Giuseppe Esposito, Daniele De Filippis, Rosa Carnuccio, Angelo A Izzo, Teresa Iuvon. The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. Journal of molecular medicine (Berlin, Germany). vol 84. issue 3. 2006-08-30. PMID:16389547. here, we report that cannabidiol inhibits hyperphosphorylation of tau protein in abeta-stimulated pc12 neuronal cells, which is one of the most representative hallmarks in ad. 2006-08-30 2023-08-12 Not clear
D V Ary, E Lichtenstein, H H Severso. Smokeless tobacco use among male adolescents: patterns, correlates, predictors, and the use of other drugs. Preventive medicine. vol 16. issue 3. 1987-07-08. PMID:3588577. smokeless tobacco use was related to the use of other drugs, with 83% of male daily users indicating concurrent use of alcohol, marijuana, and/or cigarettes (tau = 0.354, 0.210, and 0.284, respectively). 1987-07-08 2023-08-11 Not clear